11 – 20 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.
(
- Contribution to journal › Article
-
Mark
Outstanding scientists in the world of organ dysfunction. Introducing Professor Stig Bengmark
(
- Contribution to journal › Article
-
Mark
Role of nuclear factor-kappaB, reactive oxygen species and cellular signaling in the early phase of acute pancreatitis.
(
- Contribution to journal › Article
-
Mark
Influence of mast cells on the expression of adhesion molecules on circulating and migrating leukocytes in acute pancreatitis-associated lung injury
(
- Contribution to journal › Article
- 2004
-
Mark
Novel understanding of pathophysiology and potential intervention in acute pancreatitis based on studies of gene-modified mice.
(
- Contribution to journal › Scientific review
- 2003
-
Mark
Bio-phenotypes of circulating, recruiting, and migrated leukocytes in acute lung injury induced by acute pancreatitis and abdominal sepsis
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Lactobacilli attenuate bacteremia and endotoxemia associated with severe intra-abdominal infection
(
- Contribution to journal › Article
-
Mark
Acute phase response in acute pancreatitis: a comparison with abdominal sepsis.
(
- Contribution to journal › Article
- 2002
-
Mark
Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats.
(
- Contribution to journal › Article
-
Mark
Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1.
(
- Contribution to journal › Article